High Dimensional Mass Cytometry Analysis of the Effects of Vedolizumab in Intestinal Cellular Subsets and its Correlation with Clinical Parameters
High Dimensional Mass Cytometry Analysis of the Effects of Vedolizumab in Intestinal Cellular Subsets and its Correlation with Clinical Parameters
批准号:
9910384
负责人:
Jesus Rivera-Nieves
金额:
$17.81万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-08 至 2022-03-31
关键词:
AddressAffectAlgorithmsAntibodiesBiopsyBlood CellsCD3 AntigensCell SeparationCell physiologyCellsClinicalClinical ResearchClinical TrialsCluster AnalysisColonoscopyComplexCrohn&aposs diseaseCytometryData AnalysesData SetDevelopmentDiseaseDisease remissionDrug TargetingEndotheliumFailureFlow CytometryGenetic TranscriptionGoalsHistologicHomingHumanImmuneImmunophenotypingIndustryInflammatory Bowel DiseasesInfrastructureIntegrin alpha ChainsIntegrinsIntestinal MucosaIntestinesIsotopesLabelLamina PropriaLeadLeukocytesLigandsLightLogisticsLymphocyteManuscriptsMass Spectrum AnalysisMembraneMetalsMethodologyMolecularMononuclearOutcomePathogenesisPatientsPharmaceutical PreparationsPopulationResolutionSamplingStainsSurfaceSurrogate MarkersSuspensionsTNF geneTechniquesTechnologyTestingTimeantibody conjugateautomated analysisbiobankclinical practicecomputerized toolscytokinedata acquisitiondrug efficacyeffective therapyfallshealinghigh dimensionalityinfliximabinsightmucosal addressin cell adhesion molecule-1natalizumabnew therapeutic targetnovelperipheral bloodprospectiverecruitreduce symptomsresponsesample collectionsuccesstargeted treatmenttooltranscription factor
中文摘要
项目摘要
我们对Vedolizumab和其他有效治疗药物消耗的特定细胞亚群的了解,
肠内的药剂保持浅表。这部分是由于技术限制,
对人体肠固有层的细胞和分子组成进行无偏见的调查。
最近,这些技术挑战已经被质谱细胞术的发展所克服,
能够同时定量细胞亚群上多达40种表面和/或细胞内标记物。我们
我最近采用了以前主要用于外周血的现有质量细胞计数方法
细胞分析,以允许询问肠固有层细胞。我们已经开发、测试和
优化了一组37个免疫细胞标记,使我们能够同时识别所有主要的免疫细胞,
群体以及许多亚群、细胞内细胞因子和转录因子。这里我们
将前瞻性评估Vedolizumab对肠道细胞组成的影响,
免疫细胞亚群的免疫表型,之前和之后的药物的管理。然后我们将
确定细胞亚群的变化是否与临床、内镜或组织学参数相关,
疾病活动。这些研究将测试质谱细胞计数结果作为替代标记物的有效性。
靶向淋巴细胞转运的药物(Vedolizumab、etrolizumab、抗MAdCAM-1、ozanimod)和
可以直接阐明这些交通靶向疗法的具体作用机制。
英文摘要
Project Summary
Our understanding of the specific cell subsets that are being depleted by vedolizumab and other effective
agents within the intestine remains superficial. This is in part due to technical limitations which had hampered
the unbiased interrogation of cellular and molecular composition of the human intestinal lamina propria.
Recently, these technological challenges have been overcome by the development of mass cytometry, which
enables the simultaneous quantification of up to 40 surface and/or intracellular markers on cell subsets. We
have recently adapted existing mass cytometry methodology previously employed mainly for peripheral blood
cell analyses, to allow for the interrogation of intestinal lamina propria cells. We have developed, tested and
optimized a panel of 37 immune cell markers that allow us to simultaneously identify all major immune cell
populations, as well as numerous sub-populations, intracellular cytokines and transcription factors. Here we
will prospectively assess the effects of vedolizumab on the cellular composition of intestine by performing deep
immunophenotyping of immune cell subsets, prior to and after the drug’s administration. We will then
determine whether changes on cell subsets correlate with clinical, endoscopic or histologic parameters of
disease activity. These studies will test the validity of mass cytometry outcomes as surrogate markers for the
efficacy of drugs that target lymphocyte traffic (vedolizumab, etrolizumab, anti- MAdCAM-1, ozanimod) and
may directly shed light on the specific mechanism of action of these traffic-targeted therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing Mentoring of Diverse Early Career Researchers
-
批准号:10797836
-
项目类别:
-
资助金额:$11.19万
-
财政年份:2023
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Control by Beta 7 integrins of the bacterial triggers of IBD
-
批准号:10481726
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Integrin αEβ7-dependent IgA transcytosis during homeostasis and IBD
-
批准号:10591538
-
项目类别:
-
资助金额:$64.37万
-
财政年份:2022
-
负责人:Jesus Rivera-Nieves
-
依托单位:
HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues
-
批准号:10488262
-
项目类别:
-
资助金额:$78.61万
-
财政年份:2021
-
负责人:Jesus Rivera-Nieves
-
依托单位:
HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues
-
批准号:10364543
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2021
-
负责人:Jesus Rivera-Nieves
-
依托单位:
HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues
-
批准号:10675778
-
项目类别:
-
资助金额:$78.21万
-
财政年份:2021
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Regulation by Sphingosine-1-phosphate in Inflammatory Bowel Disease
-
批准号:10292938
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Regulation by Sphingosine-1-phosphate in Inflammatory Bowel Disease
-
批准号:9562862
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Regulation by Sphingosine-1-phosphate in Inflammatory Bowel Disease
-
批准号:10045948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Manipulation: A Novel Therapeutic for Inflammatory Bowel Disease
-
批准号:8795668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Manipulation: A Novel Therapeutic for Inflammatory Bowel Disease
-
批准号:8244941
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Manipulation: A Novel Therapeutic for Inflammatory Bowel Disease
-
批准号:8142980
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Dendritic Cell Manipulation: A Novel Therapeutic for Inflammatory Bowel Disease
-
批准号:8413327
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Targeting L-Selectin in Chronic Murine Ileitis
-
批准号:8422228
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Targeting L-Selectin in Chronic Murine Ileitis
-
批准号:7731223
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Targeting L-Selectin in Chronic Murine Ileitis
-
批准号:8497453
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Lymphocyte Trafficking by Chemokines/Adhesion Molecules in Crohn's Disease
-
批准号:7873780
-
项目类别:
-
资助金额:$4.87万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Targeting L-Selectin in Chronic Murine Ileitis
-
批准号:8324560
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Targeting L-Selectin in Chronic Murine Ileitis
-
批准号:7895901
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
Targeting L-Selectin in Chronic Murine Ileitis
-
批准号:8098221
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2009
-
负责人:Jesus Rivera-Nieves
-
依托单位:
海外基金